-+ 0.00%
-+ 0.00%
-+ 0.00%

Benitec Biopharma publishes corporate presentation on BB-301 durability in oculopharyngeal muscular dystrophy dysphagia###

Reuters·03/09/2026 23:52:25

Please log in to view news